Konstantinos Avgerinos obtained his Medical Degree from the Aristotle University of Thessaloniki in Greece. He additionally acquired from the same University a MSc Degree in Medical Research Methodology obtaining his certificate with scholarship of excellence and publishing his thesis in the Stroke journal. Upon joining the Human Neuroscience Section as a Visiting Fellow, Dr. Avgerinos was selected as Research Scholar by the Office of Dietary Supplements (ODS) of NIH and was funded (2019 Funded ODS Scholar) to design and conduct a double-blinded randomized placebo-controlled clinical trial on the brain effects of the novel ketogenic supplement ketone monoester in aged humans at risk for AD. In addition to the ketone monoester trial, Dr. Avgerinos is an associate investigator in clinical studies that examine the brain effects of other novel metabolic interventions including the 5:2 calorie-restriction diet and the anti-diabetic drug empagliflozin. Dr. Avgerinos is also conducting meta-analyses of various interventions in AD and other neurological conditions. He has presented his work at International Conferences such as CTAD 2020 and ADPD 2021. He is the author of 18 manuscripts published in journals such as Stroke, Ageing Research Reviews, Experimental Gerontology, and he is the first author of 10 publications. He has reviewed manuscripts for prestigious journals including the New England Journal of Medicine, Neurology, Alzheimer’s Research & Therapy and Ageing Research Reviews and he is a member of the Editorial Board of the Aging Brain journal.